Immediate effects of arm slings on posture, balance and gait in sub-acute stroke patients: A case control study

2018 ◽  
Vol 25 (3) ◽  
pp. 141-148
Author(s):  
Anke Van Bladel ◽  
Kristine Oostra ◽  
Tanneke Palmans ◽  
Cinthia Saucedo Marquez ◽  
Dirk Cambier
2021 ◽  
Vol 9 (06) ◽  
pp. 381-391
Author(s):  
Usha Rani Pegu ◽  
◽  
Alakesh Choudhuri ◽  
Uttam Kr Nath ◽  
◽  
...  

Introduction: Stroke or Cerebrovascular accident (CVA) is a major cause of disability worldwide. The estimation of serum Total T3, Total T4 and TSH are very much essential in patients with stroke. Any disturbances in thyroid hormones may have negative influence on the outcome of acute phase of strokes. Aims And Objectives: Aims and objective was to estimate the Total T3, Total T4 and TSH of patients with acute Stroke and to compare it with age/sex matched healthy controls. Materials & Methods: This Hospital Based Case Control Study, consist of total 100 subjects out of which 50 were control ,was carried out in Jorhat Medical College & Hospital, Assam for a period of one year, from July 2017 to June 2018. Age more than 40 years of both sexes was included. Estimation for total T3, total T4, and TSH was carried out in Access 2 ImmunoAssay Systems (Beckman Coulter). Cases were selected randomly . Results And Observations: Out of 50 Stroke patients ,the age group of 50 - <60 years constituted the majority of cases(32%) . Greater preponderance of stroke was seen in males (62%) with male to female ratio of 1.63:1. Hemorrhagic stroke was found to be more common than ischemic stroke (54% V/s 46%). Hemorrhagic strokes occurred more in early age than ischemic strokes. The mean ± SD of serum Total T3 levels in stroke patients and controls were 0.960 ± 0.327 and 1.248 ± 0.269 respectively, with statistically significant mean value difference (p<0.05) when cases were compared to the controls. A greater number of low T3 was present in ischemic strokes (43.5%) when compared to hemorrhagic strokes (18.5%). Conclusion: Nonthyroidal illness syndrome (Low T3 syndrome) is observed in the present study with decreased T3 values without alteration of T4 and TSH levels. Further studies with a large sample size should attempt to investigate whether treatment of low T3 syndrome can improve the final outcome.


Stroke ◽  
2020 ◽  
Vol 51 (Suppl_1) ◽  
Author(s):  
Ting Ye ◽  
Yi Dong ◽  
Shengyan Huang

Background: The dysphagia screening in acute ischemic stroke plays an important role in patients with risk of dysphagia. The aim of this hospital-based case-control study is to explore if V-VST, as a new nurse-driven dysphagia screening tool for AIS patients, might help to reduce the rate of post-stroke pneumonia and early withdraw of feeding tube. Methods: 1598 acute ischemic stroke patients were enrolled in this study. The standard protocol in AIS patients were assessed by WST (before intervention and plus with V-VST after intervention). The V-VST assessment were be trained in two senior nurses and all AIS patients were assessed by V-VST during July 1and Dec 30 th , 2017. Among 299 AIS patients with suspected, all clinical data were analyzed. The comparison of their rate of pneumonia in hospital and withdraw rate of tubefeeding before discharge were performed between patients post-intervention (January 1, 2018-June 30, 2019)and those admitted before the intervention (January 1, 2016-June 30, 2017). Results: The baseline characteristics of the pre- and post- intervention AIS groups were similar in age, gender, NIHSS. The implementation of V-VST have a statistically significant reducing the risk of pneumonia with an adjusted HR (0.60, 95% CI 0.43-0.84, P=0.003). Additionally, follow-up V-VST were likely to be associated the withdraw rate of tube-feeding at discharge (29/168 vs 38/131 P=0.016).There is also a trend of length of tube-feeding decreasing (8.32±12.27 vs 6.84±8.61 P=0.241). Conclusion: In our study, the V-VST is a feasible bedside tool. The implemental might be associated with the reduction of post-stroke pneumonia. Therefore, it meets the requirements of a clinical screening test for dysphagia in acute stroke patients at bedside. Large prospective interventional study is needed to confirm our findings. V-VST: Volume-viscosity Swallow Test WST: Water Swallow Test AIS: Acute Ischemic Stroke HR: hazard ratio


2014 ◽  
Vol 18 (6) ◽  
pp. 1084-1090 ◽  
Author(s):  
Parvane Saneei ◽  
Mohammad Saadatnia ◽  
Forough Shakeri ◽  
Masumeh Beykverdi ◽  
Ammar Hassanzadeh Keshteli ◽  
...  

AbstractObjectiveWe aimed to examine the association between red meat consumption and stroke in a group of Iranian adults.DesignA hospital-based case–control study.SettingThe study included stroke patients and hospital-based controls. Usual dietary intakes of participants were assessed by means of a validated 168-item semi-quantitative FFQ. Total red meat consumption was calculated by summing up the consumption of red, processed and visceral meats.SubjectsOne hundred and ninety-five cases were stroke patients hospitalized in the neurology ward and 195 controls were recruited from patients hospitalized in other wards with no history of cerebrovascular diseases or neurological disorders.ResultsParticipants with stroke were older, more likely to be male and less likely to be obese. Individuals in the highest tertile of red meat intake were 119 % more likely to have stroke (OR=2·19; 95 % CI 1·33, 3·60) compared with those in the lowest tertile. After controlling for age, sex and total energy intake, the association between red meat consumption and stroke was strengthened (OR=2·72; 95 % CI 1·53, 4·83). This association remained significant even after further controlling for physical activity and smoking as well as dietary intakes. Additional adjustments for BMI, diabetes, hypertension and hyperlipidaemia did not influence the association significantly (OR=2·51; 95 % CI 1·19, 5·09).ConclusionsConsumption of red meat was associated with greater odds of having stroke in a group of Iranian adults.


Author(s):  
Timothy A. Ekwere ◽  
Olufisayo G. Ayoade ◽  
Bertha C. Ekeh ◽  
Franklin O. Dike

Background: Stroke is one of the leading causes of morbidity and mortality globally. In recent time, there is increasing evidence that suggest that increased plasma fibrinogen is associated with increased risk of stroke with unfavourable clinical outcome. Objectives: To determine the plasma fibrinogen levels in stroke patients and compare with healthy controls. Study Design: The study design was Prospective case- control study.  Place and Duration of Study: The study was conducted in the department of Internal Medicine (Neurology Unit) and the department of Haematology between March to August, 2019. Methodology: A case- control study consisting of 41 patients (21M: 19F) diagnosed with stroke in line with WHO definition and confirmed by CT-Scan of the brain were recruited consecutively into the study. 20 (10M: 10F) healthy age and gender matched consenting adults were used as controls. Plasma fibrinogen was determined for both the patients and controls using ELISA method. Also, socio-demographic and clinical data were collected using questionnaire designed for the study. The level of significance was set at P=.05. Results: The mean plasma fibrinogen level of 458.0 ± 89.1 was significantly higher in the stroke patients compared to the controls 307.8 ± 61.5 (P<0.001). An increasing level of plasma fibrinogen was observed with increasing age in both the patients and controls. However, this increase was not statistically significant (P=0.98). Also, the plasma fibrinogen level was significantly higher in the female patients (501.21±83.96) than the males 420.59±77.02 (P=0.003). Conclusion: Plasma fibrinogen was significantly higher in the stroke patients compared to the controls with female patients having a significantly higher levels than males. Also, the plasma fibrinogen levels appear to increase proportionally with increasing age.


Author(s):  
Bastiaan W. Haak ◽  
Willeke F. Westendorp ◽  
Tjitske S. R. van Engelen ◽  
Xanthe Brands ◽  
Matthijs C. Brouwer ◽  
...  

Abstract In recent years, preclinical studies have illustrated the potential role of intestinal bacterial composition in the risk of stroke and post-stroke infections. The results of these studies suggest that bacteria capable of producing volatile metabolites, including trimethylamine-N-oxide (TMAO) and butyrate, play opposing, yet important roles in the cascade of events leading to stroke. However, no large-scale studies have been undertaken to determine the abundance of these bacterial communities in stroke patients and to assess the impact of disrupted compositions of the intestinal microbiota on patient outcomes. In this prospective case–control study, rectal swabs from 349 ischemic and hemorrhagic stroke patients (median age, 71 years; IQR: 67–75) were collected within 24 h of hospital admission. Samples were subjected to 16S rRNA amplicon sequencing and subsequently compared with samples obtained from 51 outpatient age- and sex-matched controls (median age, 72 years; IQR, 62–80) with similar cardiovascular risk profiles but without active signs of stroke. Plasma protein biomarkers were analyzed using a combination of nuclear magnetic resonance (NMR) spectroscopy and liquid chromatography–mass spectrometry (LC-MS). Alpha and beta diversity analyses revealed higher disruption of intestinal communities during ischemic and hemorrhagic stroke compared with non-stroke matched control subjects. Additionally, we observed an enrichment of bacteria implicated in TMAO production and a loss of butyrate-producing bacteria. Stroke patients displayed two-fold lower plasma levels of TMAO than controls (median 1.97 vs 4.03 μM, Wilcoxon p < 0.0001). Finally, lower abundance of butyrate-producing bacteria within 24 h of hospital admission was an independent predictor of enhanced risk of post-stroke infection (odds ratio 0.77, p = 0.005), but not of mortality or functional patient outcome. In conclusion, aberrations in trimethylamine- and butyrate-producing gut bacteria are associated with stroke and stroke-associated infections.


Neurology ◽  
2012 ◽  
Vol 78 (Meeting Abstracts 1) ◽  
pp. P04.069-P04.069
Author(s):  
M. Kaddumukasa ◽  
L. Goldstein ◽  
P. Duncan ◽  
E. Ddumba

Sign in / Sign up

Export Citation Format

Share Document